Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Enobia Pharma (Canada) a clinical-stage biotech company focused on hypophosphatasia, closed a $40M Series D financing. Participants include OrbiMed, CTI Life Sciences Fund, Desjardins Venture Capital and Lothian Partners. Thanx for your patience as we catch-up.

Enobia Pharma (Canada) a clinical stage biopharma focused on therapeutic enzyme replacement therapy for Hypophosphatasia, a genetic bone disorders, closed a $50M Series C financing. Participants include OrbiMed Advisors, CTI Life Sciences Fund, Fonds de solidarite FTQ, Desjardins Venture Capital and Lothian Partners.


to top of page...